Celcuity Inc.
NASDAQ: CELC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Brian F. Sullivan
- Employees
- 87
- Headquarters
- Minneapolis, United States
- IPO year
- 2017
- Market cap
- $4.3B
- Website
- https://www.celcuity.com
Loading CELC…
Loading profile data…Frequently asked questions about CELC
What does Celcuity Inc. (CELC) do?
Operating as a clinical-stage biotechnology company, Celcuity Inc. is dedicated to pioneering precision cancer treatments for patients across the United States. At the heart of their approach is the CELsignia diagnostic platform, which examines live tumor cells from patients. This innovative system aims to uncover the precise cellular dysfunctio...
Where does CELC trade?
Celcuity Inc. (CELC) trades on the NASDAQ Capital Market.
What sector is CELC in?
Celcuity Inc. (CELC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Celcuity Inc.?
Brian F. Sullivan is the chief executive officer of Celcuity Inc. (CELC).
Where is Celcuity Inc. headquartered?
Celcuity Inc. is headquartered in United States.
Does CELC pay a dividend?
Celcuity Inc. (CELC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CELC go public?
Celcuity Inc. (CELC) completed its initial public offering in 2017.